ABCELLERA BIOLOGICS INC's ticker is ABCL and the CUSIP is 00288U106. A total of 2 filers reported holding ABCELLERA BIOLOGICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,262,709 | -48.8% | 274,502 | -28.1% | 0.05% | -48.4% |
| Q2 2023 | $2,465,304 | +255.4% | 381,626 | +314.8% | 0.09% | +220.7% |
| Q1 2023 | $693,680 | -69.6% | 92,000 | -60.1% | 0.03% | -67.4% |
| Q3 2022 | $2,279,000 | -21.5% | 230,400 | -15.5% | 0.09% | -28.8% |
| Q2 2022 | $2,903,000 | +19.6% | 272,612 | +9.5% | 0.12% | +20.2% |
| Q1 2022 | $2,427,000 | +213.6% | 248,900 | +360.1% | 0.10% | +112.2% |
| Q4 2021 | $774,000 | -4.8% | 54,100 | +33.4% | 0.05% | -16.9% |
| Q3 2021 | $813,000 | -68.4% | 40,547 | -65.3% | 0.06% | -76.2% |
| Q2 2021 | $2,570,000 | – | 116,800 | – | 0.25% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DCVC Bio GP, LLC | 29,411 | $313,000 | 100.00% |
| Founders Fund VII Management, LLC | 3,773,530 | $40,188,000 | 93.02% |
| Gruss & Co., LLC | 363,778 | $3,874,000 | 26.99% |
| Founders Fund Growth Management, LLC | 407,017 | $4,334,000 | 12.66% |
| GUARDIAN CAPITAL ADVISORS LP | 3,836,414 | $44,387,000 | 5.09% |
| HARVARD MANAGEMENT CO INC | 4,105,095 | $43,719,000 | 5.06% |
| Intellectus Partners, LLC | 1,089,755 | $11,606,000 | 3.99% |
| ArchPoint Investors | 630,326 | $6,713,000 | 2.66% |
| BRANDYWINE MANAGERS, LLC | 56,976 | $607,000 | 1.49% |
| Orbimed Advisors | 4,180,768 | $44,525,000 | 0.81% |